Effect of clindamycin and a live biotherapeutic on the reproductive outcomes of IVF patients with abnormal vaginal microbiota: protocol for a double-blind, placebo-controlled multicentre trial
Introduction Recent studies in in vitro fertilisation (IVF) patients have associated abnormal vaginal microbiota (AVM) with poor clinical pregnancy rates of 6%–9% per embryo transfer. The biological plausibility for this finding is hypothesised to be ascending infection to the endometrium which in t...
Saved in:
| Main Authors: | Niels Uldbjerg, Nina La Cour Freiesleben, Anja Pinborg, Peter Humaidan, Henriette Svarre Nielsen, Thor Haahr, Vibeke Hartvig, Anne-Lis Mikkelsen, Thomas Parks, Jørgen Skov Jensen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/10/e035866.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of clindamycin and LACTIN-V for in vitro fertilization patients with vaginal dysbiosis: a randomised double-blind, placebo-controlled multicentre trial
by: Thor Haahr, et al.
Published: (2025-06-01) -
Differential characteristics of vaginal versus endometrial microbiota in IVF patients
by: Alina Polifke, et al.
Published: (2024-12-01) -
Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
by: Kyle P. Martin, et al.
Published: (2023-12-01) -
Treatment with the anti-IgE monoclonal antibody omalizumab in women with asthma undergoing fertility treatment: a proof-of-concept study—The PRO-ART study protocol
by: Karsten Kristiansen, et al.
Published: (2020-11-01) -
Cryomicroneedle Arrays for Biotherapeutics Delivery
by: Chunli Yang, et al.
Published: (2025-08-01)